| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.00017 | 1 |